<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1d3 20150301//EN"  "JATS-archivearticle1.dtd"><article article-type="research-article" dtd-version="1.1d3" xmlns:xlink="http://www.w3.org/1999/xlink"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">72657</article-id><article-id pub-id-type="doi">10.7554/eLife.72657</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Genetics and Genomics</subject></subj-group><subj-group subj-group-type="heading"><subject>Microbiology and Infectious Disease</subject></subj-group></article-categories><title-group><article-title>Deep-sequence phylogenetics to quantify patterns of HIV transmission in the context of a universal testing and treatment trial - BCPP/ Ya Tsie trial</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes" id="author-247942"><name><surname>Magosi</surname><given-names>Lerato E</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-3388-9892</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="corresp" rid="cor1">*</xref><xref ref-type="other" rid="par-1"/><xref ref-type="other" rid="par-2"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-248460"><name><surname>Zhang</surname><given-names>Yinfeng</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-94978"><name><surname>Golubchik</surname><given-names>Tanya</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-2765-9828</contrib-id><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-155844"><name><surname>DeGruttola</surname><given-names>Victor</given-names></name><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-248461"><name><surname>Tchetgen Tchetgen</surname><given-names>Eric</given-names></name><xref ref-type="aff" rid="aff5">5</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-248462"><name><surname>Novitsky</surname><given-names>Vladimir</given-names></name><xref ref-type="aff" rid="aff6">6</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-248463"><name><surname>Moore</surname><given-names>Janet</given-names></name><xref ref-type="aff" rid="aff7">7</xref><xref ref-type="other" rid="par-2"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-248471"><name><surname>Bachanas</surname><given-names>Pam</given-names></name><xref ref-type="aff" rid="aff7">7</xref><xref ref-type="other" rid="par-2"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-248464"><name><surname>Segolodi</surname><given-names>Tebogo</given-names></name><xref ref-type="aff" rid="aff8">8</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-248465"><name><surname>Lebelonyane</surname><given-names>Refeletswe</given-names></name><xref ref-type="aff" rid="aff9">9</xref><xref ref-type="other" rid="par-2"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-248466"><name><surname>Pretorius Holme</surname><given-names>Molly</given-names></name><xref ref-type="aff" rid="aff10">10</xref><xref ref-type="other" rid="par-2"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-248467"><name><surname>Moyo</surname><given-names>Sikhulile</given-names></name><xref ref-type="aff" rid="aff11">11</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-248468"><name><surname>Makhema</surname><given-names>Joseph</given-names></name><xref ref-type="aff" rid="aff11">11</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-248469"><name><surname>Lockman</surname><given-names>Shahin</given-names></name><xref ref-type="aff" rid="aff12">12</xref><xref ref-type="other" rid="par-2"/><xref ref-type="fn" rid="conf2"/></contrib><contrib contrib-type="author" id="author-6466"><name><surname>Fraser</surname><given-names>Christophe</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="other" rid="par-3"/><xref ref-type="other" rid="par-4"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-248470"><name><surname>Essex</surname><given-names>Myron (Max)</given-names></name><xref ref-type="aff" rid="aff6">6</xref><xref ref-type="other" rid="par-2"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-16032"><name><surname>Lipsitch</surname><given-names>Marc</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-1504-9213</contrib-id><xref ref-type="aff" rid="aff13">13</xref><xref ref-type="corresp" rid="cor2">*</xref><xref ref-type="other" rid="par-3"/><xref ref-type="fn" rid="conf3"/></contrib><on-behalf-of>on behalf of the Botswana Combination Prevention Project and the PANGEA consortium</on-behalf-of><aff id="aff1"><institution content-type="dept">Department of Epidemiology</institution>, <institution>Harvard University</institution>, <addr-line><named-content content-type="city">Boston</named-content></addr-line>, <country>United States</country></aff><aff id="aff2"><institution content-type="dept">Division of Molecular and Genomic Pathology</institution>, <institution>University of Pittsburgh Medical Center</institution>, <addr-line><named-content content-type="city">Pittsburgh</named-content></addr-line>, <country>United States</country></aff><aff id="aff3"><institution content-type="dept">Big Data Institute, Nuffield Department of Medicine</institution>, <institution>University of Oxford</institution>, <addr-line><named-content content-type="city">Oxford</named-content></addr-line>, <country>United Kingdom</country></aff><aff id="aff4"><institution content-type="dept">Department of Biostatistics</institution>, <institution>Harvard T H Chan School of Public Health</institution>, <addr-line><named-content content-type="city">Boston</named-content></addr-line>, <country>United States</country></aff><aff id="aff5"><institution content-type="dept">Department of Statistics</institution>, <institution>University of Pennsylvania</institution>, <addr-line><named-content content-type="city">Philadelphia</named-content></addr-line>, <country>United States</country></aff><aff id="aff6"><institution content-type="dept">Department of Immunology and Infectious Disease</institution>, <institution>Harvard T H Chan School of Public Health</institution>, <addr-line><named-content content-type="city">Boston</named-content></addr-line>, <country>United States</country></aff><aff id="aff7"><institution content-type="dept">Division of Global HIV/AIDS and TB</institution>, <institution>Centers for Disease Control and Prevention</institution>, <addr-line><named-content content-type="city">Atlanta</named-content></addr-line>, <country>United States</country></aff><aff id="aff8"><institution content-type="dept">HIV Prevention Research Unit</institution>, <institution>Centers for Disease Control and Prevention</institution>, <addr-line><named-content content-type="city">Gaborone</named-content></addr-line>, <country>Botswana</country></aff><aff id="aff9"><institution>Ministry of Health</institution>, <addr-line><named-content content-type="city">Gaborone</named-content></addr-line>, <country>Botswana</country></aff><aff id="aff10"><institution content-type="dept">epartment of Immunology and Infectious Disease</institution>, <institution>Harvard T H Chan School of Public Health</institution>, <addr-line><named-content content-type="city">Boston</named-content></addr-line>, <country>United States</country></aff><aff id="aff11"><institution>Botswana Harvard AIDS Institute Partnership</institution>, <addr-line><named-content content-type="city">Gaborone</named-content></addr-line>, <country>Botswana</country></aff><aff id="aff12"><institution content-type="dept">Division of Infectious Diseases</institution>, <institution>Brigham and Women's Hospital</institution>, <addr-line><named-content content-type="city">Boston</named-content></addr-line>, <country>United States</country></aff><aff id="aff13"><institution content-type="dept">Department of Immunology and Infectious Diseases</institution>, <institution>Harvard TH Chan School of Public Health</institution>, <addr-line><named-content content-type="city">Boston</named-content></addr-line>, <country>United States</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor" id="author-142345"><name><surname>Di Giallonardo</surname><given-names>Francesca</given-names></name><role>Reviewing editor</role><aff><country>Australia</country></aff></contrib></contrib-group><author-notes><corresp id="cor1"><label>*</label>For correspondence: <email>lmagosi@hsph.harvard.edu</email> (LM);</corresp><corresp id="cor2"><label>*</label>For correspondence: <email>mlipsitc@hsph.harvard.edu</email> (ML);</corresp></author-notes><pub-date date-type="pub" publication-format="electronic"><day>01</day><month>03</month><year>2022</year></pub-date><volume>11</volume><elocation-id>e72657</elocation-id><history><date date-type="received"><day>30</day><month>07</month><year>2021</year></date><date date-type="accepted"><day>08</day><month>02</month><year>2022</year></date></history><permissions><license xlink:href="http://creativecommons.org/publicdomain/zero/1.0/"><license-p>This is an open-access article, free of all copyright, and may be freely reproduced, distributed, transmitted, modified, built upon, or otherwise used by anyone for any lawful purpose. The work is made available under the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/publicdomain/zero/1.0/">Creative Commons CC0</ext-link> public domain dedication.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-72657-v1.pdf"/><abstract><p><bold>Background:</bold> Mathematical models predict that community-wide access to HIV testing-and-treatment can rapidly and substantially reduce new HIV infections. Yet several large universal test-and-treat HIV prevention trials in high-prevalence epidemics demonstrated variable reduction in population-level incidence.</p><p><bold>Methods:</bold> To elucidate patterns of HIV spread in universal test-and-treat trials we quantified the contribution of geographic-location, gender, age and randomized-HIV-intervention to HIV transmissions in the 30-community Ya Tsie trial in Botswana. We sequenced HIV viral whole genomes from 5,114 trial participants among the 30 trial communities.</p><p><bold>Results:</bold> Deep-sequence phylogenetic analysis revealed that most inferred HIV transmissions within the trial occurred within the same or between neighboring communities, and between similarly-aged partners. Transmissions into intervention communities from control communities were more common than the reverse post-baseline (30% [12.2 - 56.7] versus 3% [0.1 - 27.3]) than at baseline (7% [1.5 - 25.3] versus 5% [0.9 - 22.9]) compatible with a benefit from treatment-as-prevention.</p><p><bold>Conclusion:</bold> Our findings suggest that population mobility patterns are fundamental to HIV transmission dynamics and to the impact of HIV control strategies.</p><p><bold>Funding:</bold> This study was supported by the National Institute of General Medical Sciences (U54GM088558); the Fogarty International Center (FIC) of the U.S. National Institutes of Health (D43 TW009610); and the President’s Emergency Plan for AIDS Relief through the Centers for Disease Control and Prevention (CDC) (Cooperative agreements U01 GH000447 and U2G GH001911).</p></abstract><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Viruses</kwd></kwd-group><funding-group><award-group id="par-1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000061</institution-id><institution>Fogarty International Center</institution></institution-wrap></funding-source><award-id>D43 TW009610</award-id><principal-award-recipient><name><surname>Magosi</surname><given-names>Lerato E</given-names></name></principal-award-recipient></award-group><award-group id="par-2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000030</institution-id><institution>Centers for Disease Control and Prevention</institution></institution-wrap></funding-source><award-id>U01 GH000447 and U2G GH001911</award-id><principal-award-recipient><name><surname>Magosi</surname><given-names>Lerato E</given-names></name><name><surname>Moore</surname><given-names>Janet</given-names></name><name><surname>Bachanas</surname><given-names>Pam</given-names></name><name><surname>Lebelonyane</surname><given-names>Refeletswe</given-names></name><name><surname>Pretorius Holme</surname><given-names>Molly</given-names></name><name><surname>Lockman</surname><given-names>Shahin</given-names></name><name><surname>Essex</surname><given-names>Myron (Max)</given-names></name></principal-award-recipient></award-group><award-group id="par-3"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000002</institution-id><institution>National Institutes of Health</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>Fraser</surname><given-names>Christophe</given-names></name><name><surname>Lipsitch</surname><given-names>Marc</given-names></name></principal-award-recipient></award-group><award-group id="par-4"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/100000865</institution-id><institution>Bill and Melinda Gates Foundation</institution></institution-wrap></funding-source><principal-award-recipient><name><surname>Fraser</surname><given-names>Christophe</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group></article-meta></front><back><sec id="s1" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interest</title><fn fn-type="conflict" id="conf2"><p>Shahin Lockman, participates in a data safety monitoring board for NIH-funded study of PK of TB drugs and antiretrovirals in children and on a scientific advisory board for observational study of DTG programmatic rollout in Botswana. Is also a member of the Finance Board and a member of the Board of Directors for the Botswana Harvard AIDS Institute Partnership. Receives no financial compensation for these roles, and has no other competing interests to declare..</p></fn><fn fn-type="conflict" id="conf3"><p>Marc Lipsitch, is a Reviewing Editor for eLife. Has received consultancy fees from Merck, University of Virginia Miller Center and Janssen, and has performed unpaid consultancy work for Janssen, Pfizer and Astra Zeneca. Has also received payments or honoraria from Sanofi Pasteur and Bristol Myers Squibb. ML has no other competing interests to declare..</p></fn><fn fn-type="conflict" id="conf1"><p>The other authors declare that no competing interests exist.</p></fn></fn-group><fn-group content-type="ethics-information"><title>Ethics</title><fn fn-type="other"><p>Human subjects: The BCPP study was approved by the Botswana Health Research and Development Committee and the institutional review board of the Centers for Disease Control and Prevention; and was monitored by a data and safety monitoring board and Westat. Written informed consent for enrollment in the study and viral HIV genotyping was obtained from all participants.</p></fn></fn-group></sec><sec id="s2" sec-type="supplementary-material"><title>Additional Files</title><sec id="s3" sec-type="data-availability"><title>Data availability</title><p>All relevant data are within the paper, figures and tables. HIV-1 viral whole genome consensus sequences are provided as a Dryad dataset (https://doi.org/10.5061/dryad.0zpc86706). HIV-1 reads are available on reasonable request through a concept sheet proposal to the PANGEA consortium. Contact details are provided on the consortium website (www.pangea-hiv.org).Code availability: Algorithms to estimate HIV transmission flows within and between population groups accounting for sampling variability and corresponding confidence intervals have been implemented as an R package, bumblebee that will be made available at the following URL: https://magosil86.github.io/bumblebee . A step-by-step tutorial on how to estimate HIV transmission flows with bumblebee and accompanying example datasets can be accessed at: https://github.com/magosil86/bumblebee/blob/master/vignettes/bumblebee-estimate-transmission-flows-and-ci-tutotial.md .</p><p>The following datasets were generated:</p><p><element-citation id="dataset1" publication-type="data" specific-use="isSupplementedBy"><person-group person-group-type="author"><collab>Magosi LE</collab><collab>Zhang Y</collab><collab>Golubchik T</collab><collab>DeGruttola V</collab><collab>Tchetgen Tchetgen E</collab><collab>Novitsky V</collab><collab>Moore J</collab><collab>Bachanas P</collab><collab>Segolodi T</collab><collab>Lebelonyane R</collab><collab>Pretorius Holme M</collab><collab>Moyo S</collab><collab>Makhema J</collab><collab>Lockman S</collab><collab>Fraser C</collab><collab>Essex M</collab><collab>Lipsitch M</collab></person-group><year iso-8601-date="2022">2022</year><source>Deep-sequence phylogenetics to quantify patterns of HIV transmission in the context of a universal testing and treatment trial - BCPP/ Ya Tsie trial</source><ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.5061/dryad.0zpc86706">http://dx.doi.org/10.5061/dryad.0zpc86706</ext-link><comment>Dryad Digital Repository, doi:10.5061/dryad.0zpc86706</comment></element-citation></p></sec><supplementary-material><ext-link xlink:href="elife-72657-supp-v1.zip">Download zip</ext-link><p>Any figures and tables for this article are included in the PDF. The zip folder contains additional supplemental files.</p></supplementary-material></sec></back></article>